p-c-Src (Tyr 530): sc-101803. Western blot analysis of phosphorylated c-Src expression in untreated (A) and EGF + serium-treated (B) 293 whole cell lysates.
p-c-Src (Tyr 530): sc-101803. Immunoperoxidase staining of formalin-fixed, paraffin-embedded human breast carcinoma tissue showing cytoplasmic staining.
p-c-Src (Tyr 530): sc-101803. Western blot analysis of c-Src phosphorylation in untreated (A), EGF treated (B) and EGF and lambda protein phosphatase treated (C) HEK293 whole cell lysates.
p-c-Src (Tyr 530): sc-101803. Western blot analysis of c-Src phosphorylation in non-transfected: sc-117752 (A) and human c-Src transfected: sc-176936 (B) 293T whole cell lysates.
p-c-Src (Tyr 530): sc-101803. Western blot analysis of c-Src phosphorylation in pervanadate treated (A) and pervanadate and lambda protein phosphatase treated (B) Jurkat whole cell lysates.
p-c-Src (Tyr 530): sc-101803. Western blot analysis of c-Src phosphorylation in untreated (A) and lambda protein phosphatase treated (B) Jurkat whole cell lysates.
Western blot analysis of c-Src phosphorylation in untreated (A, D), prevanadate treated (B, E) and prevanadate and lambda protein phosphatase treated (C, F) Jurkat whole cell lysates. Antibodies tested include p-c-Src (Tyr 530): sc-101803 (A, B, C) and c-Src (17AT28): sc-130124 (D, E, F).
Western blot analysis of c-Src phosphorylation in untreated (A,D), serum starved and EGF treated (B,E) and serum starved, EGF and lambda protein phosphatase treated (C,F) HEK293 whole cell lysates. Antibodies tested include p-c-Src (Tyr 530): sc-101803 (A,B,C) and c-Src (17AT28): sc-130124 (D,E,F).